In recent years the use of HDAC inhibitors has emerged as a potential therapy against cancer and neurodegenerative disorders, including Parkinson's, Alzheimer's, Huntington's diseases and amyotrophic lateral sclerosis. The gene discussed is HDAC9; the disease is Parkinson disease.